Global Trust Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Global Trust Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.9K	Sell	213 -5	-2%	-$376	0.01%	314
2026 Q1	$16.4K	Hold	218	–	–	0.01%	335
2025 Q4	$17.2K	Hold	218	–	–	0.01%	313
2025 Q3	$14.3K	Hold	218	–	–	0.01%	373
2025 Q2	$8.61K	Sell	218 -181	-45%	-$5.92K	﹤0.01%	386
2025 Q1	$12K	Hold	399	–	–	0.01%	349
2024 Q4	$13.9K	Sell	399 -75	-16%	-$2.8K	0.01%	388
2024 Q3	$19K	Hold	474	–	–	0.01%	348
2024 Q2	$22.6K	Hold	474	–	–	0.01%	309
2024 Q1	$20.5K	Hold	474	–	–	0.01%	312
2023 Q4	$24K	Hold	474	–	–	0.01%	288
2023 Q3	$21.5K	Buy	474 +75	+19%	+$3.09K	0.01%	290
2023 Q2	$16.4K	Hold	399	–	–	0.01%	306
2023 Q1	$14.3K	Hold	399	–	–	0.01%	299
2022 Q4	$15.1K	Hold	399	–	–	0.01%	284
2022 Q3	$18K	Hold	399	–	–	0.01%	288
2022 Q2	$15K	Hold	399	–	–	0.01%	295
2022 Q1	$15K	Hold	399	–	–	0.01%	351
2021 Q4	$12K	Hold	399	–	–	﹤0.01%	335
2021 Q3	$13K	Hold	399	–	–	0.01%	306
2021 Q2	$16K	Hold	399	–	–	0.01%	297
2021 Q1	$18K	Buy	+399	New	+$22.3K	0.01%	263

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Global Trust Asset Management's IONS Position: Q2 2026 in Review

Global Trust Asset Management reduced its Ionis Pharmaceuticals (IONS) stake by 2.3% in Q2 2026, selling an estimated $376 and leaving 213 shares worth $16.9K. The position accounts for 0.01% of the portfolio, ranked #314.

Global Trust Asset Management first reported a position in IONS in Q1 2021 and has held it in 22 quarters since. The position peaked at $24K in Q4 2023. 515 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

Global Trust Asset Management held 213 shares of Ionis Pharmaceuticals worth $16.9K as of Q2 2026.
Global Trust Asset Management sold 5 Ionis Pharmaceuticals shares in Q2 2026, an estimated $376.
Ionis Pharmaceuticals made up 0.01% of Global Trust Asset Management's portfolio in Q2 2026, its #314 holding.
Global Trust Asset Management first reported a position in Ionis Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
Global Trust Asset Management's Ionis Pharmaceuticals position peaked at $24K in Q4 2023.
515 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Global Trust Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.